L&G PHARMA BREAKTHROUGH ETF |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.15 USD | +0.76% |
|
+0.88% | -13.95% |
| 2018 | ETFS Pharma Breakthrough GO UCITS ETF has Changed its Name to L&G Pharma Breakthrough UCITS ETF | CI |
Investment objective
The L&G Pharma Breakthrough UCITS ETF (the 'ETF') aims to track the performance of the Solactive Pharma Breakthrough Value Index (the 'Index').
| Name |
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| |
|---|---|---|---|---|---|---|
| 286.6 USD | -0.35% | +4.18% | +30.28% | 2.55% | ||
| 270 SEK | -0.81% | -4.34% | +0.67% | 2.55% | ||
| 3,145 JPY | +1.45% | -0.63% | +1.78% | 2.50% | ||
| - RUB | - | - | - | 2.48% | ||
| - CAD | -.--% | - | - | 2.48% | ||
| - AUD | -.--% | - | - | 2.48% | ||
| - USD | -.--% | - | - | 2.48% | ||
| - AUD | -.--% | - | - | 2.48% | ||
| - EUR | -.--% | - | - | 2.48% | ||
| - EUR | -.--% | - | - | 2.48% | ||
| - NOK | -.--% | - | - | 2.48% | ||
| 0.214 EUR | -.--% | - | - | 2.48% | ||
| - GBX | -.--% | - | - | 2.48% | ||
| 0.3938 CAD | -17.11% | - | - | 2.48% | ||
| 21.1 CAD | -0.24% | - | - | 2.48% | ||
| 162.5 DKK | -2.49% | -10.10% | -8.42% | 2.41% | ||
| 231.6 USD | -0.97% | +2.63% | -10.59% | 2.40% | ||
| 6,256 JPY | -2.40% | -9.10% | -11.29% | 2.38% | ||
| 5,422 JPY | -3.09% | -6.08% | +40.03% | 2.37% | ||
| 1,832 DKK | +0.47% | -5.05% | -14.97% | 2.37% | ||
More news
In partnership with
Description
| IE00BF0H7608 | |
|---|---|
| Total Expense Ratio | 0.49% |
| Asset Class | |
| Sector | |
| Size | |
| Currency | |
| Provider | |
| Underlying | Solactive Pharma Breakthrough Value NTR Index - USD |
Features and characteristics
| Jurisdiction | |
| Replication Method | |
| Replication Model | |
| Date of creation |
2018-01-22
|
| Dividend Policy | |
| Geographical Focus |
AuM evolution ( 2024-05-30 )
| AuM (EUR) | 17 M€ |
|---|---|
| AuM 1M | 17 M€ |
| AuM 3 months | 21 M€ |
| AuM 6 months | 28 M€ |
| AuM 12 months | 56 M€ |
- Stock Market
- ETF
- BIOT ETF
